Actualités Medicis Pharmaceutical Corp. - MRX | Actions New York Stock Exchange

Votre Hub pour des idées et discussions en direct en temps réel

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Garmin Set to Join the S&P 500; R.R. Donnelly & Sons to Join S&P MidCap 400

Garmin Set to Join the S&P 500; R.R. Donnelly & Sons to Join S&P MidCap 400 /* Style Definitions */ span.prnews_span { font-size:8p...

Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms

Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Ar...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Annual Report (management Company) (nsar-b)

000 B000000 09/30/2012 000 C000000 0000778365 000 D000000 N 000 E000000 NF 000 F000000 Y 000 G000000 N 000 H000000 N 000...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Valeant Pharmaceuticals Announces New Management Appointments

Valeant Pharmaceuticals Announces New Management Appointments /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; co...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medicis Pharmaceutical Corp. (MRX)

Votre Hub pour des idées et discussions en direct en temps réel

MRX Actualités

- Current report filing (8-K)

Garmin Set to Join the S&P 500; R.R. Donnelly & Sons to Join S&P MidCap 400

Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms

- Current report filing (8-K)

Current Report Filing (8-k)

Annual Report (management Company) (nsar-b)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Valeant Pharmaceuticals Announces New Management Appointments

- Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medicis Pharmaceutical Corp. (MRX) Actualités

Medicis Pharmaceutical Corp. (MRX)

Votre Hub pour des idées et discussions en direct en temps réel

MRX Actualités

- Current report filing (8-K)

Garmin Set to Join the S&P 500; R.R. Donnelly & Sons to Join S&P MidCap 400

Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms

- Current report filing (8-K)

Current Report Filing (8-k)

Annual Report (management Company) (nsar-b)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Valeant Pharmaceuticals Announces New Management Appointments

- Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités